Related references
Note: Only part of the references are listed.Infliximab prevents increased systolic blood pressure and upregulates the AKT/eNOS pathway in the aorta of spontaneously hypertensive rats
Ademir Gazzoto Filho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials
Hisato Takagi et al.
HYPERTENSION RESEARCH (2013)
Vascular Actions of Aldosterone
Marie Briet et al.
JOURNAL OF VASCULAR RESEARCH (2013)
Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure
Valeria Nasser Figueiredo et al.
BLOOD PRESSURE (2012)
Resistant and refractory hypertension: Reflections on pathophysiology and terminology
Heitor Moreno et al.
BLOOD PRESSURE (2012)
The Relationship between Resistant Hypertension and Arterial Stiffness
Turker Pabuccu et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2012)
Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes
Arianna Carolina Rosa et al.
INFLAMMATION RESEARCH (2012)
Refractory Hypertension: Definition, Prevalence, and Patient Characteristics
Maria Czarina Acelajado et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity
Luc M. Van Bortel et al.
JOURNAL OF HYPERTENSION (2012)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Determinants of Aortic Stiffness: 16-Year Follow-Up of the Whitehall II Study
Nanna B. Johansen et al.
PLOS ONE (2012)
T Regulatory Lymphocytes Prevent Angiotensin II-Induced Hypertension and Vascular Injury
Tlili Barhoumi et al.
HYPERTENSION (2011)
Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness
L. C. Martins et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Endogenous Interleukin-10 Inhibits Angiotensin II-Induced Vascular Dysfunction
Sean P. Didion et al.
HYPERTENSION (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2009)
Blood Pressure Response Under Chronic Antihypertensive Drug Therapy The Role of Aortic Stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) Study
Athanase Protogerou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Resistant Arterial Hypertension Is Associated With Higher Blood Levels of Complement C3 and C-Reactive Protein
Eli Magen et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta
Stella Brill et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension
Gil F. Salles et al.
HYPERTENSION (2007)
Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension
Walneia Aparecida De Souza et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism
James M. Luther et al.
HYPERTENSION (2006)
Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension
Panagiota Pietri et al.
JOURNAL OF HYPERTENSION (2006)
Arterial stiffness is related to systemic inflammation in essential hypertension
A Mahmud et al.
HYPERTENSION (2005)
Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals
C Vlachopoulos et al.
CIRCULATION (2005)
Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
LE Bautista et al.
JOURNAL OF HUMAN HYPERTENSION (2005)
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients
S Laurent et al.
HYPERTENSION (2001)
Association of serum tumour necrosis factor-α with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women
H Ito et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Acute systemic inflammation impairs endothelium-dependent dilatation in humans
AD Hingorani et al.
CIRCULATION (2000)
Share Paper
